-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ISB-1302
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ISB-1302 Drug Details ISB-1302 (GBR-1302) is under development for the treatment of HER2 positive...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ISB-1342
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ISB-1342 Drug Details ISB-1342 (GBR-1342) is under development for the treatment of multiple myeloma...
-
Sector Analysis
Germany Meat Substitutes Market Size and Trend Analysis by Categories and Segment, Distribution Channel, Packaging Formats, Market Share, Demographics and Forecast, 2021-2026
Germany Meat Substitutes Market Report Overview The Germany meat substitutes market size was valued at EUR317.1 million ($375 million) in 2021 and is expected to achieve a CAGR of more than 16% during 2021-2026. Hypermarkets & supermarkets accounted for the leading share in the distribution of meat substitute products in the country. Germany Meat Substitutes Market Outlook 2021-2026 (EUR Million) Buy the Full Report for More Insights on Germany Meat Substitutes Market Revenue, Download A Free Report Sample The Germany...
-
Product Insights
Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Glaucoma signs and symptoms include eye pain, nausea and vomiting (accompanying the severe eye pain), sudden onset of visual disturbance, often in low light, blurred vision, and reddening of the eye. The Glaucoma pipeline drugs market research report provides an analysis of the Glaucoma drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and...
-
Product Insights
Optic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Optic Neuropathy pipeline market research report provides an overview of the Optic Neuropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Optic Neuropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of...
-
Product Insights
Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H1, 2018" provides an overview of Multiple Myeloma (Kahler Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Multiple Myeloma (Kahler Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2018" provides an overview of Refractory Multiple Myeloma clinical trials scenario. This report provides top line data relating to the clinical trials on Refractory Multiple Myeloma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Relapsed Multiple Myeloma Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Relapsed Multiple Myeloma Global Clinical Trials Review, H1, 2018" provides an overview of Relapsed Multiple Myeloma clinical trials scenario. This report provides top line data relating to the clinical trials on Relapsed Multiple Myeloma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
Consumer and Market Insights: Spirits in Germany
The Germany Spirits market will be positively impacted by an improving GDP per capita and low inflation rates. The Spirits market in Germany is led by the Specialty Spirits category in terms of volume in 2015, while the Liqueurs category leads the Spirits market in value terms. The Liqueurs category is forecast to register fastest growth among all categories during 2015-2020. Hypermarkets & Supermarkets is the leading distribution channel in Germany’s Spirits market. The Whiskey category has the highest penetration...